I am totally OK for Elite not to show profit as long as I see 20 Million in Inventory that will disappear from the shelves very quickly and also to see that we have $1.9 Million in R&D.and I see the company expanding. and I do not see crazy spending like other pharmas - this company is well run.
This is a company which is expanding like no other company on the OTC is expanding.
Remember: each % of Vyvanse is worth $43 Million. Remember - the DEA had no choice but add 24% quota tof Branded Vyvanse o Takeda back in September 2024. We will hear today SOMETHING about the Vyvanse Quota.
Market Data 
Markets 
AI
